{
  "items": [
    {
      "title": "Johnson & Johnson Announces New Icotrokinra (JNJ-2113) Data from its Comprehensive Phase 3 Clinical Program",
      "description": "Johnson & Johnson announced new icotrokinra data from its comprehensive Phase 3 clinical program and the start of the first-ever head-to-head study in plaque psoriasis seeking to demonstrate the...",
      "published_utc": "2025-03-08T17:00:00",
      "source": "Finnhub",
      "url": "https://finnhub.io/api/news?id=2da198b2a3586fc4f64993da1d20fdf3f7f174e126dcc0ac4d976c6026e4eb8c",
      "category": "company",
      "image": "",
      "related_symbols": [
        "JNJ"
      ],
      "api_source": "finnhub_company",
      "id": 133107876,
      "datetime": 1741424400
    }
  ]
}